Microbiome and urine microbiota: modern concepts and gender features

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The review article provides definitions and presents current data on the biological significance of the microbiome and microbiota of urine. The urinary microbiota is less well understood than the intestinal microbiota, but its biological role is complex and multifaceted. To date, its importance in the formation of colonization resistance, which prevents the invasion of uropathogens, is obvious. An analysis of methods for assessing the microbiome and microbiota of urine was carried out. The shortcomings of widely used standard microbiological research methods are shown. The method of 16S rRNA gene sequencing is described in detail. Information about the gender characteristics of the urine microbiota and the results of its study in healthy women and men are given. Further progress in the study of the urobiome is associated with the acquisition of new technologies for genomic research and the development of bioinformatics.

Full Text

MICROBIOTA AND MICROBIOME: BASIC CONCEPTS

The human body is inhabited by numerous microorganisms that are in symbiotic relationships with each other and with the host organism. All of them are united in the collective concept of microbiota that characterizes the totality of microbial communities more accurately than the term microflora that refers to plants. Organs and systems, namely, intestines, skin, vagina, and biliary tract, etc., have their microbiota. The human microbiota contains approximately 1013–1014 cells, including more than 40,000 bacterial strains that belong to 1800 genera and up to 10 million unique genes [1–3]. Moreover, the human microbiota includes not only bacteria but also archaea, eukaryotes, such as protozoa, fungi, nematodes, and viruses. The human microbiota composition is quite specific and individualized. In addition, some changes in the microbiota may be noted with the aging of the organism and in response to various exogenous and endogenous influences.

The totality of all genomes of the human microbiota is referred to as the microbiome. It was proposed by the American scientist Joshua Lederberg in 2001 [4]. The amount of genetic information in the gut microbiota alone is approximately 100 times greater than that of the human genome [5]. In general, the concept of microbiome refers to the ecosystem inhabited by microorganisms, which interact with it and use its resources. The study of genes responsible for the formation of the microbiota of various localizations is recognized as one of the most promising fields of research in biomedicine.

The microbiota of each person is unique and is important in maintaining macro-organism homeostasis. The biological role of the microbiota cannot be overestimated. This system influences its owner and interacts with him/her, adapting to the signals and information coming from him/her. Through microorganisms, a person performs functions that are not encoded by his/her genome, that is, provides protection against virulent pathogens, receives additional energy from food, promotes the synthesis of biologically active substances, performs immunogenic, mutagenic, or antimutagenic functions, and participates in carcinolytic reactions [6].

For a long time, the dogma of sterility of the urine of a healthy person was not questioned in medical science. In such cases, it was assumed that the urine does not contain microorganisms. This concept was supported mainly by the imperfection of laboratory diagnostic methods, although many clinicians noted that in patients with cystitis symptoms and multiple negative results of urine cultures, treatment with antibiotics often leads to the disappearance of symptoms. In 1979, a group of British microbiologists led by Rosalind Maskell, while incubating “sterile” urine under conditions of high carbon dioxide content, isolated slowly growing gram-positive microorganisms, thereby proving the above concept as false [7]. Modern laboratory technologies detect microorganisms of 1210–1420 species in urine, whereas healthy people have no more than 12% of them. Moreover, under various pathological conditions, their number increases significantly, for example, up to 25% of microbial species are detected in patients who underwent kidney transplantation [8]. The microbiome of the urinary tract began to be carefully studied much later than the microbiome of other organs and systems. Thus, in connection with the prevailing concept of urine sterility in a healthy person, its study was included in the Human Microbiome Project of the US National Institutes of Health only in 2012, 5 years after its start. However, the results obtained during this project unequivocally confirmed the fact that the urine of healthy people is nonsterile and contains numerous anaerobic and aerobic microorganisms [9–11]. Therefore, we had to reconsider the existing ideas about the etiology and pathogenesis of many diseases. Nowadays, the imbalance of the urinary microbiota is undoubtedly important in the development of not only urinary infections but also other urological diseases [12–14].

METHODS FOR STUDYING THE MICROBIOTA AND URINE MICROBIOME

Traditionally, the detection of microorganisms in the urine has been based on the results of standard urine cultures. According to the clinical guidelines of the Ministry of Health of the Russian Federation on bacteriological analysis of urine in 2014, for microbiological research, universal, selective, or differential diagnostic media intended for cultivation must be used under a normal atmosphere at 35–37 °C for 18–24 h [15]. International laboratories also used several nutrient media (blood agar and McConkey agar) and aerobic cultivation conditions at 35 °C [16]. These methods have very limited capabilities because they detect a relatively small number of microorganisms, mainly aerobic fast-growing bacteria, such as Escherichia coli [17]. In standard cultures, up to 92% of false-negative results were recorded [16].

An expanded quantitative urine culture (EQUC) is much more sensitive and can detect up to 72% of urobiome microorganisms [18]. In EQUC, a 100 µL of urine sample is inoculated on culture media (blood agar, colistin–nalidixic acid agar, and McConkey agar) and incubated in 5% CO2 for 48 h. In a study by Price et al. [19], only 33% of uropathogens were detected by standard urine culture, whereas the optimized EQUC protocol allowed the identification of 84% of microorganisms. With this method, Hilt et al. [16] identified 35 different genera and 85 bacterial phyla in urine samples of women, and the most common microorganisms were from the genera Lactobacillus (15%), Corynebacterium (14.2%), Streptococcus (11.9%), Actinomyces (6.9%), and Staphylococcus (6.9%).

The results of both standard and extended urine cultures are influenced by several factors that must be considered in data interpretation. These include the method of urine sampling (suprapubic puncture, bladder catheterization, and natural urination), uneven spatial distribution of microorganisms in different sections of the urinary tract, sex differences, age-related characteristics, presence of concomitant diseases, intake of antibacterial and other drugs, diet, physical activity, and environmental factors [20].

When studying the urinary tract microbiota, the gold standard is considered the sequencing of the nucleic acids of microorganisms, that is, the determination of their nucleotide sequence. In 2012, Wolfe et al. [21] conducted sequencing of the 16S ribosomal RNA (rRNA) gene, revealed microflora in the urine of healthy women, and thus put an end to the false myth about urine sterility. Subsequently, sequencing became widespread both in scientific research and clinical practice. However, this technique is not standardized, which limits the possibility of its even wider use. Two types of sequencing are known, namely, whole genome sequencing (WGS) and metagenomic sequencing [22]. WGS is performed to determine the genome of a specific bacterium, whereas metagenomic sequencing is performed on mixed populations of microorganisms. Metagenomic sequencing aimed to identify the microorganisms present in a particular study sample. Most studies of the microbiome, including urine, are based on the sequencing of the 16S rRNA gene of prokaryotic microorganisms. The 16S rRNA gene is ubiquitous in all bacteria, whereas it is absent in mammals and contains nine hypervariable regions (V1–V9) [23], which enables identifying various bacteria by taxonomic comparison of the resulting sequences with the reference genomes from international databases. Depending on the sequence and choice of databases, identification can be performed down to the species level; however, usually, it results in a combination of species, genera, and phyla of microorganisms [18]. To describe the results of such identification, the general term “operational taxonomic unit” is often used, which combines decoded 16S rRNA gene sequences with 97% identity, which is usually sufficient to understand the species of microbes. This process is called metataxonic. Viruses and fungi do not have the 16S rRNA gene and, therefore, cannot be detected, although they are an integral part of the microbiome.

In accordance with modern concepts, the concept of “sterile” should not be used in relation to the urinary tract [24]. In general, the urine microbiota is less numerous and diverse than that of other localizations. For example, the female urine microbiota averaged 104–105 colony-forming units (CFU)/mL compared with 1012 CFU/g in feces [25].

The data obtained by urinary 16S rRNA sequencing indicate that the urinary microbiome at the phyla level in men and women is almost the same. In both sexes, the majority of bacteria belong to the Firmicutes phylum (men, 65%; women, 73%). The other most common phyla of organisms found in the urine are Actinobacteria (men, 15%; women, 19%), Bacteroidetes (men, 10%; women, 3%), and Proteobacteria (men, 8%; women, 3%) [26]. Representatives of these types of bacteria account for up to 97% of all urine microorganisms. The main sex differences in the urobiome are manifested in the form of the dominance of some genera of microorganisms depending on sex. Thus, bacteria of the Corynebacterium and Streptococcus are more often found in men, and Lactobacillus are more often detected in women [26, 27].

URINE MICROBIOME OF HEALTHY WOMEN

The urine of healthy women of all age groups is nonsterile, which was proven by sequencing in 2012 by Wolfe et al. [21]. The urine contains numerous microorganisms with a predominance of Lactobacillus spp., Prevotella spp., and Gardnerella spp. [28].

Representatives of Lactobacillus are the most numerous among microorganisms found in the urine microbiome of healthy women [29]. However, not all Lactobacillus species are associated with healthy microbiota. Thus, Lactobacillus crispatus is characteristic of the urobiome of healthy women, and Lactobacillus gasseri is more often isolated from women with urge urinary incontinence [25]. The prevalence of Lactobacillus spp. in young women decreased during the postmenopausal period, which contributes to the colonization of the urinary tract by uropathogens and the development of urinary tract infections [29].

Gardnerella is frequently isolated from urine samples of healthy women [30]. However, G. vaginalis often causes bacterial vaginosis and contributes to the development of recurrent lower urinary tract infections. The mechanism of the pathological action of G. vaginalis was studied by Gilbert et al. [31]. Exposure of the bladder to G. vaginalis promotes the release of E. coli from intracellular bladder reservoirs and causes cystitis recurrence. The authors revealed that even short-term exposure to G. vaginalis causes apoptosis of the bladder epithelium and exfoliation, which persisted even after the disappearance of G. vaginalis from the urinary tract [31]. These data indicate that the overgrowth of G. vaginalis is a possible trigger for urinary tract infections.

Naboka et al. [32] conducted a consistent series of studies on the structure of microbiota in healthy women by using the polymerase chain reaction (PCR) and microbiological methods, and the test material was inoculated on nutrient media for facultative anaerobic bacteria (FAB) and nonclostridial anaerobic bacteria (NAB). No sterile cultures were found in a bacteriological study of 60 urine samples from healthy sexually active women. In all cases, microorganisms were present in different variants of multicomponent associations of FAB and NAB. In the FAB group, coagulase-negative staphylococci and Corynebacterium spp. were detected during the day at >60%. In the NAB group, Eubacterium spp., Peptococcus spp., Propionibacterium spp., and Lactobacillus spp. were detected more often. The level of bacteriuria for all microorganisms verified in the urine of healthy women in the vast majority of cases was <103 CFU/mL. No significant differences were noted in the frequency of detection of various bacterial genera in the urine during the day [32].

The origin of bacteria from the microbial community of urine remains unclear. The anatomical proximity of the genital and urinary tracts suggests that the vagina may be the main source of the urinary microbial community. In 2016, Naboka et al. [33] studied the microbiota of the urine and vagina of healthy postmenopausal women. For this purpose, 20 conditionally healthy women (mean age 59.0 ± 2.1 years), who were in the climacteric period for >8 years, were examined. A bacteriological examination of urine and vagina was performed on an expanded set of nutrient media for the cultivation of FAB and NAB and PCR of a midstream specimen of morning urine. In both urine and vagina, FAB was detected with a predominance of coagulase-negative staphylococci, and the bacterial patterns of the studied biotopes were comparable. Moreover, NAB Megasphaera spp., Veillonella spp., Prevotella spp., Mobiluncus spp., and Fusobacterium spp. were detected in the urine, whereas they were absent in the vagina. Cluster analysis did not reveal significant differences in the concentration of the same microorganisms isolated from the urine and vagina. Thomas-White et al. [34] conducted a metagenomic analysis of bacterial strains isolated from the vagina and bladder and revealed a significant similarity between them, for both uropathogens (E. coli and S. anginosus) and commensal microorganisms (Lactobacillus iners and L. crispatus). The results of the two aforementioned studies support the need to evaluate the bladder microbiota in women in the context of the vaginal microbiota.

The intestines are a possible source of microorganisms in the urine. Dubourg et al. [35] analyzed 435 urine samples and isolated 450 different types of bacteria; 256 of them had never been found in urine before. Among the identified bacterial species, 161 (35%) were anaerobic microorganisms; 64.1% of all isolated species of bacteria were previously detected in the intestinal microbiota, and only 31.7% were found in the vaginal microbiota. These results suggest that many representatives of the urinary tract microbiota are actually from the gut [35]. The reduction in the recurrence rate of lower urinary tract infections after fecal microbiota transplantation supports the hypothesis of the importance of intestinal microflora in urinary infection development [36].

Curtiss et al. [37] studied the age-related aspects of the urine microbiota in women. Older women have decreased amounts of Lactobacillus, and postmenopausal women have increased amounts of Mobiluncus representatives in the urine, which are gram-positive rod-shaped anaerobes [37]. A possible reason for such changes is a decrease in estrogen level, which leads both to the elimination of lactobacilli and development of dystrophic and atrophic processes in the mucous membranes of the lower urinary tract.

URINE MICROBIOME OF HEALTHY MEN

Studies that focused on the microbiome of urine in men is much less than that in women. In general, the male urobiome is characterized by lower diversity of microorganisms [30]. Most authors indicate the predominance of Corynebacterium spp. and Streptococcus spp. in the male microbiota [17, 38, 39]. Nelson et al. [38] identified 72 genera of bacteria in the urine microbiome of healthy men; in addition to the two genera mentioned above, large amounts of Sneatia spp. and Lactobacillus spp. were noted. The proportion of Lactobacillus representatives in men is significantly less than that in women [40]. Staphylococcus haemolyticus is also often detected in healthy men [41].

In 2014, authors from the Rostov State Medical University studied the composition of the microbiota of the lower urinary tract and genital organs of healthy men. A bacteriological examination of urine and ejaculate was performed on an expanded set of nutrient media for FAB and NAB. The dominant FAB clusters were Corynebacterium spp. and coagulase-negative staphylococci (67.9% each), and Eubacterium spp. were dominant among NAB [42].

The urobiome of men aged >70 years is characterized by a high diversity of microorganisms, which potentially correlates with an increased risk of kidney, prostate, and bladder diseases [43].

CONCLUSION

The urinary tract microbiota is less investigated than the intestinal microbiota; however, its biological role is complex and multifaceted. To date, its importance in the formation of colonization resistance, which prevents the invasion of uropathogens, is apparent. The imbalance of microorganisms detected in various urinary system pathologies can be one of the key links in the pathogenesis of their development, the effect on which will help create new treatment and prevention methods in the future. The study of the relationship between the intestinal microbiota and urobiome would radically change the approaches to the treatment of patients with recurrent urinary tract infections.

Further progress in the study of the urobiome is associated with the acquisition of new technologies for genomic research and bioinformatic development. In addition, research on the microbiome is already advancing to a qualitatively new level, from describing its composition and studying the mechanisms of functioning to developing individual therapeutic agents based on the protective properties of the microbiota.

ADDITIONAL INFORMATION

Author contribution. Thereby, all authors made a substantial contribution to the conception of the work, acquisition, analysis, interpretation of data for the work, drafting and revising the work, final approval of the version to be published and agree to be accountable for all aspects of the work.

Competing interests. The authors declare that they have no competing interests.

Funding source. This study was not supported by any external sources of funding.

×

About the authors

Margarita N. Slesarevskaya

Academician I.P. Pavlov First St. Petersburg State Medical University

Author for correspondence.
Email: mns-1971@yandex.ru
ORCID iD: 0000-0002-4911-6018
SPIN-code: 9602-7775
Scopus Author ID: 57196117211

Cand. Sci. (Med.), Senior Researcher

Russian Federation, Saint Petersburg

Igor V. Kuzmin

Academician I.P. Pavlov First St. Petersburg State Medical University

Email: kuzminigor@mail.ru
ORCID iD: 0000-0002-7724-7832
SPIN-code: 2684-4070
Scopus Author ID: 56878681300

Dr. Sci. (Med.), Professor of the Department of Urology

Russian Federation, Saint Petersburg

Kairkhan G. Zhumadillayev

Academician I.P. Pavlov First St. Petersburg State Medical University

Email: kairyoyo@mail.ru

Student

Russian Federation, Saint Petersburg

Gleb A. Vvedenskiy

Academician I.P. Pavlov First St. Petersburg State Medical University

Email: vvedenskiy.99@mail.ru

Student

Russian Federation, Saint Petersburg

Yury А. Mikheev

Academician I.P. Pavlov First St. Petersburg State Medical University

Email: Mikheevyra@gmail.com

Student

Russian Federation, Saint Petersburg

Albina V. Maksimova

Academician I.P. Pavlov First St. Petersburg State Medical University

Email: maksimova_av77@mail.ru
ORCID iD: 0000-0002-5627-2596

Student

Russian Federation, Saint Petersburg

References

  1. Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016;14(8): e1002533. doi: 10.1371/journal.pbio.1002533
  2. Gilbert JA, Blaser MJ, Caporaso JG, et al. Current understanding of the human microbiome. Nat Med. 2018;24:392–400. doi: 10.1038/nm.4517
  3. Li J, Jia H, Cai X, et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol. 2014;32(8):834–841. doi: 10.1038/nbt.2942
  4. Lederberg J. “Ome sweet” omics — a genealogical treasury of words. The Scientist. 2001;15(7):8.
  5. Lazebnik LB, Konev YuV. Microbiota, dysbiosis and age-related diseases. Clinical gerontology. 2020;26(1–2):43–50. (In Russ.) doi: 10.26347/1607-2499202001-02043-050
  6. Nikonov EL, Popova EN, editors. Mikrobiota. Moscow: Media Sfera, 2019. 255 p. (In Russ.)
  7. Maskell R, Pead L, Allen J. The puzzle of “urethral syndrome”: a possible answer? Lancet. 1979;313(8125):1058–1059. doi: 10.1016/s0140-6736(79)92953-2
  8. Rani A, Ranjan R, McGee HS, et al. Urinary microbiome of kidney transplant patients reveals dysbiosis with potential for antibiotic resistance. Transl Res. 2017;181:59–70. doi: 10.1016/j.trsl.2016.08.008
  9. Wolfe AJ, Brubaker L. “Sterile Urine” and the Presence of Bacteria. Eur Urol. 2015;68(2):173–174. doi: 10.1016/j.eururo.2015.02.041
  10. Whiteside SA, Razvi H, Dave S, et al. The microbiome of the urinary tract — a role beyond infection. Nat Rev Urol. 2015;12(2):81–90. doi: 10.1038/nrurol.2014.361
  11. Thomas-White K, Brady M, Wolfe AJ, Mueller ER. The bladder is not sterile: History and current discoveries on the urinary microbiome. Curr Bladder Dysfunct Rep. 2016;11(1):18–24. doi: 10.1007/s11884-016-0345-8
  12. Kadyrov ZA, Stepanov VN, Faniev MV, Ramishvili SV. Microbiota of the urogenital organs. Urologiia. 2020;(1):116–120. (In Russ.) doi: 10.18565/urology.2020.1.116-120
  13. Zakharova IN, Osmanov IM, Machneva EВ, et al. From bacteriuria to the urinary tract microbiome: the evolution of the views of researchers and clinicians. Medical Council. 2018;(17):168–177. (In Russ.) doi: 10.21518/2079-701X-2018-17-168-176
  14. Goloshchapov ET, Chetverikov AV. Microbial load of the urine in patients with recurrent urolithiasis and its correction. Urology reports (St. Petersburg). 2020;10(1):51–55. (In Russ.) doi: 10.17816/uroved10151-55
  15. Kozlov RS, Men’shikov VV, Mikhailova VS, et al. Bakteriologicheskii analiz mochi. Rukovodstvo po klinicheskoi laboratornoi diagnostike. Moscow: Ministerstvo zdravookhraneniya RF. 33 p. Available from: https://antimicrob.net/wp-content/uploads/Bakteriologicheskiy-analiz-mochi_metodicheskie-rekomendacii.pdf (In Russ.)
  16. Hilt EE, McKinley K, Pearce MM, et al. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol. 2014;52(3):871–876. doi: 10.1128/JCM.02876-13
  17. Perez-Carrasco V, Soriano-Lerma A, Soriano M, et al. Urinary Microbiome: Yin and Yang of the Urinary Tract. Front Cell Infect Microbiol. 2021;11:617002. doi: 10.3389/fcimb.2021.617002
  18. Thomas-White K, Forster SC, Kumar N, et al. Culturing of female bladder bacteria reveals an interconnected urogenital microbiota. Nat Commun. 2018;9(1):1557. doi: 10.1038/s41467-018-03968-5
  19. Price TK, Dune T, Hilt EE, et al. The Clinical Urine Culture: Enhanced Techniques Improve Detection of Clinically Relevant Microorganisms. J Clin Microbiol. 2016;54(5):1216–1222. doi: 10.1128/JCM.00044-16
  20. Malaeva EG. Urinary tract infections and microbiota. Health and Ecology Issues. 2021;18(3):5–14. (In Russ.) doi: 10.51523/2708-6011.2021-18-3-1
  21. Wolfe AJ, Toh E, Shibata N, et al. Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol. 2012;50(4): 1376–1383. doi: 10.1128/JCM.05852-11
  22. Human Microbiome Project Consortium. A framework for human microbiome research. Nature. 2012;486(7402):215–221. doi: 10.1038/nature11209
  23. Van de Peer Y, Chapelle S, De Wachter R. A quantitative map of nucleotide substitution rates in bacterial rRNA. Nucleic Acids Res. 1996;24(17):3381–3391. doi: 10.1093/nar/24.17.3381
  24. Brubaker L, Wolfe AJ. The female urinary microbiota, urinary health and common urinary disorders. Ann Transl Med. 2017;5(2):34. doi: 10.21037/atm.2016.11.62
  25. Pearce MM, Hilt EE, Rosenfeld AB, et al. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio. 2014;5(4): e01283–14. doi: 10.1128/mBio.01283-14
  26. Modena BD, Milam R, Harrison F, et al. Changes in Urinary Microbiome Populations Correlate in Kidney Transplants with Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies. Am J Transplant. 2017;17(3):712–723. doi: 10.1111/ajt.14038
  27. Fouts DE, Pieper R, Szpakowski S, et al. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J Transl Med. 2012;10:174. doi: 10.1186/1479-5876-10-174
  28. Siddiqui H, Nederbragt AJ, Lagesen K, et al. Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol. 2011;11:244. doi: 10.1186/1471-2180-11-244
  29. Stapleton AE. The Vaginal Microbiota and Urinary Tract Infection. Microbiol Spectr. 2016;4(6): UTI-0025-2016. doi: 10.1128/microbiolspec.UTI-0025-2016
  30. Kenneally C, Murphy CP, Sleator RD, Culligan EP. The urinary microbiome and biological therapeutics: Novel therapies for urinary tract infections. Microbiol Res. 2022;259:127010. doi: 10.1016/j.micres.2022.127010
  31. Gilbert NM, O’Brien VP, Lewis AL. Transient microbiota exposures activate dormant Escherichia coli infection in the bladder and drive severe outcomes of recurrent disease. PLoS Pathog. 2017;13(3): e1006238. doi: 10.1371/journal.ppat.1006238
  32. Naboka YuL, Kogan MI, Gudima IA, et al. Does the urine microbiota of healthy women vary during daytime? Nephrology (Saint Petersburg). 2016;20(5):36–42. (In Russ.)
  33. Naboka YuL, Rymashevsky AN, Kogan MI, et al. Microbiota of urine and vagina of healthy postmenopausal women (a pilot study). Urologiia. 2016;(1):18–24. (In Russ.)
  34. Thomas-White KJ, Gao X, Lin H, et al. Urinary microbes and postoperative urinary tract infection risk in urogynecologic surgical patients. Int Urogynecol J. 2018;29(12):1797–1805. doi: 10.1007/s00192-018-3767-3
  35. Dubourg G, Morand A, Mekhalif F, et al. Deciphering the Urinary Microbiota Repertoire by Culturomics Reveals Mostly Anaerobic Bacteria From the Gut. Front Microbiol. 2020;11:513305. doi: 10.3389/fmicb.2020.513305
  36. Tariq R, Pardi DS, Tosh PK, et al. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency. Clin Infect Dis. 2017;65(10):1745–1747. doi: 10.1093/cid/cix618
  37. Curtiss N, Balachandran A, Krska L, et al. Age, menopausal status and the bladder microbiome. Eur J Obstet Gynecol Reprod Biol. 2018;228:126–129. doi: 10.1016/j.ejogrb.2018.06.011
  38. Nelson DE, Van Der Pol B, Dong Q, et al. Characteristic male urine microbiomes associate with asymptomatic sexually transmitted infection. PLoS One. 2010;5(11): e14116. doi: 10.1371/journal.pone.0014116
  39. Dong Q, Nelson DE, Toh E, et al. The microbial communities in male first catch urine are highly similar to those in paired urethral swab specimens. PLoS One. 2011;6(5): e19709. doi: 10.1371/journal.pone.0019709
  40. Moustafa A, Li W, Singh H, et al. Microbial metagenome of urinary tract infection. Sci Rep. 2018;8(1):4333. doi: 10.1038/s41598-018-22660-8
  41. Groah SL, Pérez-Losada M, Caldovic L, et al. Redefining Healthy Urine: A Cross-Sectional Exploratory Metagenomic Study of People with and Without Bladder Dysfunction. J Urol. 2016;196(2):579–587. doi: 10.1016/j.juro.2016.01.088
  42. Naboka YuL, Kogan MI, Gudima IA, et al. Microbiota of lower urine tract and genital organs of healthy men and in infertility. Journal of Microbiology, Epidemiology and Immunobiology. 2015;(1):65–71. (In Russ.)
  43. Wojciuk B, Salabura A, Grygorcewicz B, et al. Urobiome: In Sickness and in Health. Microorganisms. 2019;7(11):548. doi: 10.3390/microorganisms7110548

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2022 Slesarevskaya M.N., Kuzmin I.V., Zhumadillayev K.G., Vvedenskiy G.A., Mikheev Y.А., Maksimova A.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ №ФС77-65570 от 04 мая 2016 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies